Lipicure-D 20 Tablet contains a combination of Atorvastatin 20 mg and Vitamin D3 1000 IU, formulated to support cardiovascular health and bone metabolism. Atorvastatin is a potent HMG-CoA reductase inhibitor that effectively lowers elevated low-density lipoprotein cholesterol (LDL-C), total cholesterol, and triglycerides, while modestly increasing high-density lipoprotein cholesterol (HDL-C). It is primarily indicated for the management of hypercholesterolemia, prevention of atherosclerotic cardiovascular disease, and reduction of the risk of myocardial infarction, stroke, and related complications. Vitamin D3 (cholecalciferol) plays a crucial role in calcium homeostasis and bone mineralization, aiding in the prevention and treatment of vitamin D deficiency and associated disorders such as osteoporosis. The combination in Lipicure-D 20 provides a dual therapeutic benefit by addressing lipid abnormalities and supporting bone health, especially in patients at risk of both cardiovascular disease and vitamin D insufficiency. The tablet should be administered as prescribed by a healthcare professional, typically once daily, with or without food. Regular monitoring of lipid profiles and serum vitamin D levels is recommended to assess therapeutic response and adjust dosage accordingly. Caution is advised in patients with liver impairment, renal dysfunction, or hypersensitivity to any component.